You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NGMN

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Antwerpen, Berlin, Groningen (EVRA patch (NGMN+EE) (Treatment A) (Reference), High molecular weight

Completed
  • Healthy
  • EVRA patch (NGMN+EE) (Treatment A) (Reference)
  • High molecular weight polyisobutylene (HMW PIB) patch (NGMN+EE) (Treatment B) (Test)
  • Antwerpen, Belgium
  • +2 more
Feb 6, 2020

Contraception Trial in Berlin (MR-130A-01 Transdermal patch)

Recruiting
  • Contraception
  • MR-130A-01 Transdermal patch
  • Berlin, Germany
    dinox GmbH
Sep 15, 2023

Healthy Trial in Merksem (EVRA patch (NGMN+EE) (Treatment A) (Reference), HMW PIB patch (NGMN+EE) (Treatment B) (Test))

Completed
  • Healthy
  • EVRA patch (NGMN+EE) (Treatment A) (Reference)
  • HMW PIB patch (NGMN+EE) (Treatment B) (Test)
  • Merksem, Belgium
    Clinical Pharmacology Unit
May 7, 2019

Healthy Trial in Dallas (Tirzepatide, EE/NGM)

Completed
  • Healthy
  • Dallas, Texas
    Covance Dallas
Feb 17, 2021

Headache, Migraine Trial in United States (Erenumab, Ethynil Estradiol/Norgestimate Oral Contraceptive)

Completed
Has Results
  • Headache, Migraine
  • Erenumab
  • Ethynil Estradiol/Norgestimate Oral Contraceptive
  • Anaheim, California
  • +3 more
Jun 6, 2018

Infection, Human Immunodeficiency Virus Trial (BMS-955176, Ortho Cyclen)

Completed
  • Infection, Human Immunodeficiency Virus
  • (no location specified)
Apr 13, 2018

Pharmacokinetics Trial in Boston (Xulane Contraceptive Patch)

Completed
Has Results
  • Pharmacokinetics
  • Xulane Contraceptive Patch
  • Boston, Massachusetts
    Boston Medical Center
Apr 17, 2017

ORTHO EVRA in Relation to Venous Thromboembolism, Stroke and

Completed
  • Contraception
  • Female Contraception
  • Monophasic or triphasic Oral contraceptive tablet
  • Ortho Evra transdermal patch containing 6 mg NGMN/0.75 mg EE
  • (no location specified)
Jul 15, 2016

Diabetes, Type 2 Trial in Dallas (Ortho-Cyclen, Dulaglutide)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Oct 3, 2014

Healthy Volunteers Trial in Neptune (Treatment A: ORTHO EVRA patch (NGMN + EE) with an adhesive overlay, Treatment B: ORTHO EVRA

Completed
  • Healthy Volunteers
  • Treatment A: ORTHO EVRA patch (NGMN + EE) with an adhesive overlay
  • Treatment B: ORTHO EVRA patch (NGMN + EE) without an overlay
  • Neptune, New Jersey
    (unnamed)
Mar 19, 2013

Contraception, Female Contraception Trial (EVRA transdermal contraceptive patch 6 mg NGMN and 0.75 mg EE)

Completed
  • Contraception
  • Female Contraception
  • EVRA transdermal contraceptive patch 6 mg NGMN and 0.75 mg EE
  • (no location specified)
Dec 11, 2012

Bioequivalence Study of Patches With Different Release Profiles

Completed
  • Female Contraception
    • (no location specified)
    Jun 6, 2011

    Female Contraception Trial (norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.)

    Completed
    • Female Contraception
    • norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.
    • (no location specified)
    Jun 6, 2011

    Contraception, Female Contraception Trial (EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.75 mg

    Completed
    • Contraception
    • Female Contraception
    • EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.75 mg of ethinyl estradiol (versus CILEST® tablets).
    • (no location specified)
    Jun 6, 2011

    Contraception, Female Contraception Trial (EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.60 mg

    Completed
    • Contraception
    • Female Contraception
    • EVRA® transdermal contraceptive patch containing 6 mg of norelgestromin and 0.60 mg of ethinyl estradiol (versus CILEST® tablets).
    • (no location specified)
    Jun 6, 2011

    Drug Interactions, Healthy, Pharmacokinetics Trial (Norgestimate; Ethinyl Estradiol; Folic acid)

    Completed
    • Drug Interactions
    • +2 more
    • Norgestimate; Ethinyl Estradiol; Folic acid
    • (no location specified)
    Jun 6, 2011

    Pharmacokinetics, Therapeutic Equivalency, Contraceptives, Oral Trial (Norgestimate; Ethinyl Estradiol; Folic acid.)

    Completed
    • Pharmacokinetics
    • +2 more
    • Norgestimate; Ethinyl Estradiol; Folic acid.
    • (no location specified)
    Jun 6, 2011

    Female Contraception, Contraception, Therapeutic Equivalency Trial (Norgestimate/Ehinyl Estradiol; Folic acid.)

    Completed
    • Female Contraception
    • +3 more
    • Norgestimate/Ehinyl Estradiol; Folic acid.
    • (no location specified)
    Jun 6, 2011

    Drug Interactions, Contraception, Pharmacokinetics Trial (Norgestimate; Ethinyl Estradiol; Folic acid)

    Completed
    • Drug Interactions
    • +2 more
    • Norgestimate; Ethinyl Estradiol; Folic acid
    • (no location specified)
    Jun 6, 2011

    Hepatitis C Virus Trial in Lenexa (Ortho Tri-Cyclen®, BMS-650032)

    Completed
    • Hepatitis C Virus
    • Lenexa, Kansas
      Pra International
    Jan 24, 2011

    Contraception, Female Contraception Trial (norelgestromin + ethinyl estradiol)

    Completed
    • Contraception
    • Female Contraception
    • norelgestromin + ethinyl estradiol
    • (no location specified)
    Nov 15, 2010